Creative Details

Quality Score: N/A

The advertisement promotes Fasenra as an add-on treatment for patients aged 3 and older with severe eosinophilic asthma, highlighting important safety information and contraindications.

Creative Information

CID:66bfaf86-f5bf-45e7-9b2a-67da06f2d693
CRID:82_6988-953258
Domain:fasenrahcp.com
Seat:PP
Size:728x90
Bid:$40.47
Timestamp:10/31/2025, 1:36:58 AM
Declared IAB Categories:

    Analysis

    4 succeeded1 failed(80% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess10/31/2025, 3:27:13 AM5.73s
    adomain_analysisfailed12/9/2025, 11:57:01 PMN/A
    adomain_capturesuccess10/31/2025, 5:32:46 AM0.08s
    ad_rendersuccess10/31/2025, 3:27:08 AM24.50s
    brand_mappingsuccess10/31/2025, 3:27:09 AM1.16s

    Analysis Results

    Ad Format: banner

    Brands: FASENRA

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:728x90
    Data Transferred:1433.88 KB
    Render Time:8.82 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1434.01 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js523.93
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/m202508060101/ufs_web_display.js221.76
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N5622.3848558MATTERKIND/B32817584.428719075;dc_ver=106.314;dc_eid=40004000;sz=728x90;u_sd=1;gdpr_consent=AUDIT;nel=1;kw=2838468;dc_adk=3706686476;ord=z930pl;click2=https%3A%2F%2Fsjc-tr.contextweb.com%2Fbh%2Fct2%3Fi%3DU1y1oURfbW0k~a%3D7da8e724c6bf26b994932f5e425187d0655014da~agi%3D254576~ts%3Ds6YkQ5bIZS_YQzZ9oZPEcD8Ce321UFan~es%3D2~c%3D2838468~p%3D562001~pu%3Dhttps%253A%252F%252Fwww.legacy.com%252Fus%252Fobituaries%252Fabqjournal%252Fbrowse~s%3Dcontextweb.com~dt%3D2~u%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=MkVDSA!Q(h;gcsr=m;stc=1;chaa=1;sttr=111;prcl=s100.13
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/hxE3TQCkXuxt7r_bWu7AoTGmvmaS4CIx1WF2US_DCj0.js52.50
    https://fonts.gstatic.com/s/opensans/v44/memtYaGs126MiZpBA-UFUIcVXSCEkx2cmqvXlWqWuU6FxZCJgg.woff244.02
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://c.evidon.com/geo/ba.js?r23112142.46
    https://s0.2mdn.net/879366/DcmEnabler_01_253.js33.80

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3